# VIVIMUSTA
> **NDA212209** · New Drug Application · Sponsor: AZURITY · Approved 2022-12-07
## Drug
- **FDA Application Number:** NDA212209
- **Application type:** New Drug Application
- **Brand name:** VIVIMUSTA
- **Generic name:** BENDAMUSTINE HYDROCHLORIDE
- **Active ingredients:** BENDAMUSTINE HYDROCHLORIDE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** AZURITY
- **Manufacturer:** Azurity Pharmaceuticals, Inc.
- **First approval:** 2022-12-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212209)
---
*MORVS · CC0 1.0*